14d
Is SOPHiA GENETICS SA (SOPH) Among the Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On?
On June 4, 2026, SOPHiA GENETICS SA (NASDAQ:SOPH) reported that it signed a Memorandum of Understanding with Memorial Sloan Kettering Cancer Center to form a proposed joint venture aimed at building a ...
I assign SOPHiA GENETICS a Hold rating, due to persistent losses, unpredictable revenue, and unclear path to profitability, despite strong gross margins and global expansion. The AstraZeneca ...
WESTPORT — Everyone is welcome at SOPH. The new boutique, located at 875 State Rd., offers clothing, accessories, and novelty items. With an eye on inclusivity, SOPH offers a clothing size range from ...
Sophon is shutting down its zero-knowledge Layer 2 blockchain and abandoning the traditional gas token model, marking one of ...
As of June 12, 2024, the average one-year price target for SOPHiA GENETICS is 8.84. The forecasts range from a low of 8.08 to a high of $10.50. The average price target represents an increase of 90.52 ...
As of November 9, 2025, the average one-year price target for SOPHiA GENETICS is $7.14/share. The forecasts range from a low of $6.06 to a high of $9.45. The average price target represents an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results